CINECA IRIS Institutional Research Information System

GUERRASIO, Angelo Cesare
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.876
EU - Europa 3.662
AS - Asia 1.505
AF - Africa 53
OC - Oceania 12
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 10.115
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.803
CN - Cina 1.035
SE - Svezia 605
IT - Italia 599
IE - Irlanda 513
UA - Ucraina 469
FR - Francia 346
DE - Germania 306
FI - Finlandia 301
KR - Corea 239
GB - Regno Unito 178
PL - Polonia 140
VN - Vietnam 119
AT - Austria 96
CA - Canada 66
JP - Giappone 35
IN - India 29
MU - Mauritius 28
NL - Olanda 25
SN - Senegal 23
GR - Grecia 21
BE - Belgio 19
RU - Federazione Russa 15
AU - Australia 10
SG - Singapore 8
TW - Taiwan 8
MX - Messico 5
MY - Malesia 5
RO - Romania 5
BR - Brasile 4
DK - Danimarca 4
ES - Italia 4
HK - Hong Kong 4
IL - Israele 4
NO - Norvegia 4
TR - Turchia 4
UZ - Uzbekistan 4
PT - Portogallo 3
SA - Arabia Saudita 3
BG - Bulgaria 2
EU - Europa 2
IR - Iran 2
MO - Macao, regione amministrativa speciale della Cina 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
RS - Serbia 2
AZ - Azerbaigian 1
CL - Cile 1
CZ - Repubblica Ceca 1
HU - Ungheria 1
LT - Lituania 1
LU - Lussemburgo 1
MA - Marocco 1
PH - Filippine 1
PK - Pakistan 1
SI - Slovenia 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 10.115
Salva come PNG Salva come JPEG
Città #
Beijing 813
Chandler 757
Dublin 512
Houston 347
Fairfield 330
Jacksonville 265
Villeurbanne 240
Ashburn 189
Torino 185
Woodbridge 183
Wilmington 172
Ann Arbor 171
Dearborn 159
Princeton 157
Medford 139
Warsaw 136
Seattle 131
Nyköping 125
Cambridge 103
Fremont 97
Vienna 96
Boston 95
Milan 92
Pisa 76
Dong Ket 74
Verona 65
Boardman 59
Düsseldorf 43
Nanjing 42
Lachine 35
New York 34
Redwood City 27
Washington 27
Norwalk 24
Toronto 23
Turin 23
San Mateo 21
Brussels 17
San Diego 16
Hefei 15
Phoenix 14
Vestignè 14
Falls Church 12
Kunming 12
Guangzhou 11
Nanchang 11
Zhengzhou 11
Hebei 9
Silver Spring 9
Chengdu 8
Mountain View 8
Piemonte 8
Pune 8
Taipei 8
Wuhan 7
Dronten 6
Munich 6
Napoli 6
Redmond 6
Shanghai 6
Shenyang 6
Helsinki 5
Los Angeles 5
Seoul 5
Buffalo 4
Changsha 4
Delhi 4
Hangzhou 4
Jinan 4
Kuala Lumpur 4
Nashville 4
Upper Marlboro 4
Xian 4
Central District 3
Chicago 3
Chongqing 3
Copenhagen 3
Dallas 3
Detroit 3
Fuzhou 3
Groningen 3
Haverhill 3
Mexico 3
Moscow 3
Naples 3
Ottawa 3
Philadelphia 3
San Jose 3
Scuola 3
Shenzhen 3
Singapore 3
Stavanger 3
Tappahannock 3
Tokyo 3
Wenzhou 3
Antwerpen 2
Auburn Hills 2
Auburn University 2
Baotou 2
Bologna 2
Totale 6.428
Salva come PNG Salva come JPEG
Nome #
Therapeutic inhibition of USP7-PTEN network in chronic lymphocytic leukemia: a strategy to overcome TP53 mutated/deleted clones 317
Distribution of Ha-RAS-1 proto-oncogene alleles in breast cancer patients and in a control population 189
BCR-ABL inactivates cytosolic PTEN through casein kinase II mediated tail phosphorylation 173
The BCR-ABL/NF-κB signal transduction network: a long lasting relationship in Philadelphia positive Leukemias 168
BCR-ABL Promotes PTEN Downregulation in Chronic Myeloid Leukemia. 164
ABL proteins in Philadelphia-positive acute leukaemias and chronic myelogenous leukaemia blast crises. 156
When collateral vessels matter: asymptomatic Leriche syndrome 140
Small bowel cancer diagnosis: role of nuclear magnetic resonance 133
The targetable role of herpes virus-associated ubiquitin-specific protease (HAUSP) in p190 BCR-ABL leukemia 133
Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: A GITMO study 132
Cytomegalovirus Reactivation During Alemtuzumab Treatment for Multiple Sclerosis: A Case Report 122
Mechanisms of p53 Functional De-Regulation: Role of the IκB-α/p53 Complex 116
INHIBITION OF USP7 INDUCES SELECTIVE CANCER CELL DEATH IN CHRONIC LYMPHOCYTIC LEUKEMIA THROUGH PTEN AND INDEPENDENTLY FROM P53 STATUS 114
Protein Kinase CK2: A Targetable BCR-ABL Partner in Philadelphia Positive Leukemias 113
Rare Bone Marrow Biopsy Complication: A Challenging Case of Sacroiliitis and Staphilococcus Aureus Sepsis 110
Phenotypical heterogeneity of acute myeloid leukemia in the elderly: a clue for a personalized therapy? 110
Gastropancreatic fistula in a patient with chronic pancreatitis and IPMN 107
A human leukemic T-cell line bears an abnormal and overexpressed c-myc gene: molecular and functional characterization of the rearrangement. 105
Therapy-induced Ph1 suppression in chronic myeloid leukemia: molecular and cytogenetic studies in patients treated with alpha-2b IFN, high-dose chemotherapy and autologous stem cell infusion. 105
The non-genomic loss of function of tumor suppressors: an essential role in the pathogenesis of chronic myeloid leukemia chronic phase 104
Glucagon-like peptide 1-related peptides increase nitric oxide effects to reduce platelet activation 103
Inhibition of bromodomain and extra-terminal proteins increases sensitivity to venetoclax in chronic lymphocytic leukaemia 99
Association between high on-aspirin platelet reactivity and reduced superoxide dismutase activity in patients affected by type 2 diabetes mellitus or primary hypercholesterolemia 99
Non genomic loss of function of tumor suppressors in CML: BCR-ABL promotes IκBα mediated p53 nuclear exclusion 96
A 3' truncation of MYC caused by chromosomal translocation in a human T-cell leukemia increases mRNA stability. 95
IκBα targeting promotes oxidative stress-dependent cell death 94
Inhibition OF USP7 Induces Selective Cancer Cell Death in Chronic Lymphocytic Leukemia 91
M-BCR breakpoint location does not predict survival in Philadelphia chromosome-positive chronic myeloid leukemia. 84
Expression of the hybrid P210 bcr/abl protein in Philadelphia chromosome positive B-lymphoid cell lines. 82
A novel type of c-myc translocation in a T lymphoma cell line. 82
Assessment of minimal residual disease (MRD) in CBFbeta/MYH11-positive acute myeloid leukemias by qualitative and quantitative RT-PCR amplification of fusion transcripts. 82
3' c-myc rearrangement in a human leukemic T-cell line. 82
A new TaqI polymorphism in the p53 gene. 81
Effects of PCSK9 inhibitors on platelet function in adults with hypercholesterolemia 81
Analysis of the gamma chains in a homozygote for HPFH Negro type and in three related heterozygotes. 80
G gamma and a gamma globin chain synthesis in bone marrow and peripheral blood of beta-thalassaemia homozygotes. 80
INHIBITION OF USP7 INDUCES GROWTH ARREST AND APOPTOSIS VIA PTEN IN CLL CELLS 80
Interferon-induced 'lupoid' thrombocytopenia in chronic hepatitis C. 79
Lasting Hb F reactivation and Hb A2 reduction induced by the treatment of Hodgkin's disease in a woman heterozygous for beta-thalassemia and the Swiss type of the heterocellular hereditary persistence of Hb F. 79
A gamma and G gamma globin chain synthesis in BFU-E colonies from adult, newborn, and fetal subjects and from thalassemic patients. 79
BCR breakpoint subregions and blast crisis lineage in CML patients. 78
Tumorigenic activity of a rearranged c-myc gene from a human T-cell leukemia line. 76
HAUSP compartmentalization in chronic myeloid leukemia 76
Bone marrow granulomatosis: Two case reports 76
ROLE OF HAUSP/PTEN NETWORK IN CHRONIC LYMPHOID LEUKEMIA PATHOGENESIS AND THERAPY 74
HHV8-positive, HIV-negative multicentric Castleman’s disease: early and sustained complete remission with rituximab therapy without reactivation of Kaposi sarcoma 73
GLP-1 reduces the activation of PI3K and MAPK pathways and of oxidative stress induced by Na-arachidonate in platelets. 71
High frequency of endothelial colony forming cells marks a non-active myeloproliferative neoplasm with high risk of splanchnic vein thrombosis. 70
Autologous Hematopotoietic Stem Cell Transplantation in Multiple Sclerosis with An Intermediate Intensity Conditioning Regimen: The Italian Multi-Centre Experience 70
Polyclonal haemopoieses associated with long-term persistence of the AML1-ETO transcript in patients with FAB M2 acute myeloid leukaemia in continous clinical remission 68
BCR-ABL inactivates cytosolic PTEN through casein kinase II mediated tail phosphorylation. 68
Ph positive acute lymphoblastic leukemia in adults: molecular and clinical studies. 67
Alternative BCR/ABL transcripts in chronic myeloid leukemia. 67
Glucagon-Like Peptide 1 reduces platelet activation: effects on PI-3K and MAPK pathways and oxidative stress in the presence of arachidonic acid. 67
Therapeutic inhibition of HAUSP-PTEN network in chronic lymphocytic leukemia 67
Analysis of the p53 gene in myeloid malignancies associated with chromosomal abnormalities involving the short arm of chromosome 17. 67
Identical utilization of T-cell receptor gene regions in B-lymphoid blast crisis of chronic myeloid leukemia and B-precursor acute lymphoblastic leukemia. 66
Variant breakpoint positions on chromosome 22 in Ph'-positive chronic myelogenous leukemias. 66
Autoimmune pancreatitis, IgG4-related disease, and Castleman disease: is there a link? 65
Nuclear-cytoplasmic Shuttling in Chronic Myeloid Leukemia: Implications in Leukemia Maintenance and Therapy 65
Molecular characterization of thalassemia intermedia in Italy. 64
Biosynthetic studies and gamma-chain composition in the Greek type of hereditary persistence of fetal hemoglobin and in its association with beta-thalassemia. 63
NON GENOMIC LOSS OF FUNCTION OF TUMOR SUPPRESSORS IN CML: BCR-ABL PROMOTES P53 NUCLEAR EXCLUSION THROUGH THE INTERACTION WITH IKB-ALPHA 63
Molecular cytogenetic analysis discloses complex genetic imbalance in a t(11;21) myelodysplastic syndrome. 62
Duplication of Ph and of 9q+ chromosomes during the blastic transformation of a CML case. 61
Multilineage cell involvement in Ph1-negative, bcr-negative chronic myeloid leukemia. 60
Molecular mechanisms of tumor progression in chronic myeloproliferative disorders. 60
Polymorphism of human fetal haemoglobin studied by isoelectric focusing. 58
[Biochemical and clinical studies of 2 new Italian cases of Hb G-Ferrara heterozygosis] 58
Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients 58
Cytomegalovirus reactivation during alemtuzumab treatment in a patient with multiple sclerosis 58
IκB-α: At the crossroad between oncogenic and tumor-suppressive signals 58
Variability of the molecular defects corresponding to the presence of a Philadelphia chromosome in human hematologic malignancies. 58
Transient cytogenetic relapse in a Ph1-positive chronic myelogenous leukemia patient previously treated with alpha-interferon. 58
The challenge of hemorrhagic shock management during low-molecular-weight heparin treatment 58
Immunoglobulin and Myc gene structure in lymphnode biopsies from HIV-positive patients with LAS and lymphoma. 57
BCR/ABL transcripts and leukemia phenotype: an unsolved puzzle. 57
CD7/CD56-positive acute myeloid leukemias are characterized by constitutive phosphorylation of the NF-kB subunit p65 at Ser536 57
Proto-oncogene activation in human hematologic malignancies. 56
Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life 56
The Challenging Diagnosis of Pancreatic Masses: Not All Tumors Are Cancers 56
Usefulness of quantitative assessment of the WT1 gene transcript as a marker for minimal residual disease detection 54
New type of Bcr/Abl junction in Philadelphia chromosome-positive chronic myelogenous leukemia. 54
Impairment of GLP-1 effects in platelets from subjects affected by type 2 diabetes mellitus 54
Resistance to the GLP-1 effects on platelets in type 2 diabetes mellitus 54
BCR/ABL rearrangement and leukemia phenotype. 53
Different suppression of Ph1 positive hemopoiesis induced by intensive chemotherapy in lymphoid and myeloid blast crisis of CML. 53
Resistenza agli effetti del GLP-1 sulla risposta pastrinica nel diabete di tipo 2 53
Transferrin Saturation Inversely Correlates with Platelet Function 53
Molecular defects associated with the acute phase CML. 52
BCR-ABL transcripts detected by polymerase chain reaction (PCR) after allogenic BMT for CML: analysis of 32 longterm disease free patients. 52
The human myeloma cell line LP-1: a versatile model in which to study early plasma-cell differentiation and c-myc activation. 52
New perspectives for molecular targeted therapy in human leukemias 52
Glucagon-Like Peptide 1 reduces platelet activation induced by sodium arachidonate through the inhibition of PI-3K and MAPK pathways. 52
Electrophoretic separation of A gamma and G gamma human globin chains in Nonidet P-40. 51
Clinical and haematological improvement induced by etidronate in a patient with idiopathic myelofibrosis and osteosclerosis. 51
Molecular biology to check patients treated for CML. 51
Significance of detection of BCR/ABL transcript after allogeneic and autologous transplant. 50
The three polymorphic chains of human Hb-F studied in normal Italian newborns. 50
Transferrin Saturation and Its Association with Platelet Reactivity 50
Totale 8.163
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.961
article - articoli 0
book - libri 0
conference - conferenze 4.788
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.749
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019378 0 0 0 0 0 0 0 0 0 71 239 68
2019/20201.508 54 26 93 150 146 341 180 91 161 126 82 58
2020/20211.596 108 80 154 75 181 156 137 53 200 114 123 215
2021/20221.322 36 60 48 108 29 61 72 58 53 149 257 391
2022/20232.067 247 138 48 188 217 592 164 112 190 26 106 39
2023/2024497 94 130 47 35 43 95 9 15 1 28 0 0
Totale 10.550